Skip to main navigation Skip to search Skip to main content

Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

  • Melek Cihanbeylerden
  • , João Teixeira
  • , Hazal Kayıkçı
  • , Çise Tüccar
  • , Ali Fuat Kalyoncu
  • , Ebru Damadoglu
  • , Margarida Gonçalo
  • , Gül Karakaya
  • Hacettepe University
  • University of Coimbra

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1495-1497
Number of pages3
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume80
Issue number5
DOIs
Publication statusPublished - May 2025

Cite this